Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06393712
Status:
RECRUITING
Last Update Posted:
2024-06-25
First Post:
2024-04-19
Brief Title:
A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid Angiopathy
Sponsor:
Alnylam Pharmaceuticals
Organization:
Alnylam Pharmaceuticals
Organization Data
Organization:
Alnylam Pharmaceuticals
Class:
INDUSTRY
Study ID:
ALN-APP-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Alnylam Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None